Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxi1
|
ENSMUSG00000047861.2 | forkhead box I1 |
Foxo1
|
ENSMUSG00000044167.5 | forkhead box O1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_34213030_34213193 | Foxi1 | 5022 | 0.220486 | -0.78 | 6.6e-02 | Click! |
chr11_34181831_34182010 | Foxi1 | 26169 | 0.162675 | -0.24 | 6.4e-01 | Click! |
chr3_52258651_52258810 | Foxo1 | 9606 | 0.122228 | -0.97 | 1.8e-03 | Click! |
chr3_52257597_52258053 | Foxo1 | 10511 | 0.120384 | -0.94 | 5.3e-03 | Click! |
chr3_52258108_52258303 | Foxo1 | 10131 | 0.121141 | -0.93 | 8.2e-03 | Click! |
chr3_52262582_52262733 | Foxo1 | 5679 | 0.134791 | -0.87 | 2.5e-02 | Click! |
chr3_52267357_52267508 | Foxo1 | 904 | 0.438411 | -0.80 | 5.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_128950190_128950354 | 11.84 |
Azin2 |
antizyme inhibitor 2 |
11126 |
0.15 |
chr8_91379183_91379600 | 10.55 |
Fto |
fat mass and obesity associated |
11164 |
0.15 |
chr19_58157498_58157649 | 9.33 |
Gm16277 |
predicted gene 16277 |
46566 |
0.16 |
chr13_56692137_56692672 | 9.10 |
Smad5 |
SMAD family member 5 |
10606 |
0.22 |
chr7_140772355_140773139 | 8.59 |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
8266 |
0.09 |
chr9_105878487_105878719 | 8.06 |
Col6a5 |
collagen, type VI, alpha 5 |
3203 |
0.27 |
chr7_27478150_27478347 | 7.75 |
Sertad3 |
SERTA domain containing 3 |
4480 |
0.1 |
chr4_105633062_105633239 | 7.11 |
Gm12726 |
predicted gene 12726 |
54810 |
0.16 |
chr14_116448226_116448591 | 6.93 |
Gm38045 |
predicted gene, 38045 |
301807 |
0.01 |
chr6_59424988_59425182 | 6.77 |
Gprin3 |
GPRIN family member 3 |
1209 |
0.64 |
chr16_30603170_30603355 | 6.71 |
Fam43a |
family with sequence similarity 43, member A |
3539 |
0.24 |
chr4_82306185_82306346 | 6.32 |
n-R5s188 |
nuclear encoded rRNA 5S 188 |
133145 |
0.05 |
chr5_75377802_75378010 | 6.16 |
Gm22084 |
predicted gene, 22084 |
5761 |
0.2 |
chr12_110381296_110381622 | 6.16 |
Gm47195 |
predicted gene, 47195 |
56074 |
0.08 |
chr15_7088669_7089236 | 6.09 |
Lifr |
LIF receptor alpha |
1662 |
0.5 |
chr7_98002722_98002888 | 6.07 |
Gdpd4 |
glycerophosphodiester phosphodiesterase domain containing 4 |
44984 |
0.13 |
chr14_66019718_66019895 | 6.02 |
Gulo |
gulonolactone (L-) oxidase |
10599 |
0.15 |
chr6_95936376_95936809 | 6.00 |
Gm7838 |
predicted gene 7838 |
9663 |
0.29 |
chr7_134497342_134497526 | 5.78 |
D7Ertd443e |
DNA segment, Chr 7, ERATO Doi 443, expressed |
1550 |
0.55 |
chr3_115775909_115776067 | 5.56 |
Gm9889 |
predicted gene 9889 |
60838 |
0.1 |
chr3_65663297_65663473 | 5.52 |
Lekr1 |
leucine, glutamate and lysine rich 1 |
2843 |
0.19 |
chr13_35959638_35960013 | 5.47 |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
986 |
0.42 |
chr2_132684569_132684730 | 5.29 |
Shld1 |
shieldin complex subunit 1 |
2282 |
0.18 |
chr15_3490987_3491164 | 5.27 |
Ghr |
growth hormone receptor |
19431 |
0.26 |
chr16_30953629_30953810 | 5.26 |
Gm46565 |
predicted gene, 46565 |
18090 |
0.15 |
chr7_84201215_84201396 | 5.24 |
Gm44826 |
predicted gene 44826 |
9209 |
0.15 |
chr2_84357197_84357348 | 5.16 |
Calcrl |
calcitonin receptor-like |
18086 |
0.19 |
chr16_80273340_80273491 | 5.15 |
Gm23083 |
predicted gene, 23083 |
136063 |
0.05 |
chr16_57127831_57128340 | 5.09 |
Tomm70a |
translocase of outer mitochondrial membrane 70A |
6382 |
0.18 |
chr10_71193153_71193343 | 5.08 |
1700113B09Rik |
RIKEN cDNA 1700113B09 gene |
8497 |
0.12 |
chr19_42551158_42551329 | 5.04 |
Gm16541 |
predicted gene 16541 |
11852 |
0.18 |
chr5_4737105_4737274 | 4.95 |
Fzd1 |
frizzled class receptor 1 |
20846 |
0.16 |
chr15_96372725_96372895 | 4.93 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
6004 |
0.21 |
chr19_42659668_42660167 | 4.88 |
Gm25216 |
predicted gene, 25216 |
39985 |
0.13 |
chr10_75098542_75098730 | 4.88 |
Bcr |
BCR activator of RhoGEF and GTPase |
38044 |
0.14 |
chr5_22255477_22255648 | 4.86 |
Gm16113 |
predicted gene 16113 |
26020 |
0.16 |
chr1_157073744_157073917 | 4.82 |
Gm28694 |
predicted gene 28694 |
19796 |
0.15 |
chr15_10245307_10245664 | 4.76 |
Prlr |
prolactin receptor |
4075 |
0.31 |
chr7_129793665_129794087 | 4.75 |
Gm44778 |
predicted gene 44778 |
39170 |
0.2 |
chr17_47329074_47329231 | 4.74 |
Trerf1 |
transcriptional regulating factor 1 |
35083 |
0.1 |
chr10_82758923_82759475 | 4.72 |
Nfyb |
nuclear transcription factor-Y beta |
1892 |
0.23 |
chr6_111600197_111600355 | 4.69 |
Gm22093 |
predicted gene, 22093 |
2976 |
0.4 |
chr12_79403988_79404273 | 4.68 |
Rad51b |
RAD51 paralog B |
76777 |
0.1 |
chr12_84930852_84931021 | 4.66 |
Gm17193 |
predicted gene 17193 |
7424 |
0.12 |
chr12_108304077_108304251 | 4.61 |
Hhipl1 |
hedgehog interacting protein-like 1 |
2106 |
0.27 |
chr8_54315039_54315224 | 4.55 |
Gm45553 |
predicted gene 45553 |
199019 |
0.02 |
chr8_77369753_77369904 | 4.52 |
Gm45407 |
predicted gene 45407 |
2688 |
0.28 |
chr3_129887879_129888048 | 4.52 |
Pla2g12a |
phospholipase A2, group XIIA |
4867 |
0.17 |
chr4_6913921_6914467 | 4.50 |
Tox |
thymocyte selection-associated high mobility group box |
76289 |
0.11 |
chrX_11082991_11083162 | 4.50 |
Gm14485 |
predicted gene 14485 |
62069 |
0.12 |
chr18_11858447_11858616 | 4.47 |
Cables1 |
CDK5 and Abl enzyme substrate 1 |
14231 |
0.16 |
chr5_121950251_121950441 | 4.44 |
Cux2 |
cut-like homeobox 2 |
25425 |
0.15 |
chr15_78231969_78232141 | 4.42 |
Ncf4 |
neutrophil cytosolic factor 4 |
12746 |
0.13 |
chr1_86600398_86600549 | 4.41 |
Cops7b |
COP9 signalosome subunit 7B |
3733 |
0.15 |
chr1_133190582_133190733 | 4.40 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
9336 |
0.18 |
chr9_25376297_25376471 | 4.34 |
Gm18891 |
predicted gene, 18891 |
26886 |
0.18 |
chr5_3488489_3488661 | 4.31 |
Gm17590 |
predicted gene, 17590 |
7702 |
0.13 |
chr14_51106134_51106584 | 4.31 |
Eddm3b |
epididymal protein 3B |
8067 |
0.08 |
chr2_144441501_144441698 | 4.27 |
Zfp133-ps |
zinc finger protein 133, pseudogene |
17681 |
0.14 |
chr1_133265093_133265439 | 4.23 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
4190 |
0.17 |
chr5_51039736_51040095 | 4.22 |
Gm40319 |
predicted gene, 40319 |
12466 |
0.29 |
chr5_104086712_104086871 | 4.21 |
Gm17660 |
predicted gene, 17660 |
9183 |
0.11 |
chr10_116221046_116221335 | 4.19 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
24794 |
0.18 |
chr2_148040189_148040578 | 4.19 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
180 |
0.94 |
chr6_142459207_142459594 | 4.17 |
Gys2 |
glycogen synthase 2 |
13709 |
0.16 |
chr16_95449403_95449694 | 4.15 |
Erg |
ETS transcription factor |
9697 |
0.27 |
chr14_99616632_99616869 | 4.13 |
Gm49225 |
predicted gene, 49225 |
3266 |
0.27 |
chr4_123108028_123108191 | 4.07 |
Bmp8b |
bone morphogenetic protein 8b |
2944 |
0.16 |
chrX_47259642_47259793 | 4.07 |
Gm14609 |
predicted gene 14609 |
121617 |
0.06 |
chr19_33489637_33489788 | 4.06 |
Lipo5 |
lipase, member O5 |
16521 |
0.14 |
chr7_76651093_76651386 | 4.03 |
2310001K20Rik |
RIKEN cDNA 2310001K20 gene |
40174 |
0.19 |
chr7_49358786_49358938 | 3.99 |
Nav2 |
neuron navigator 2 |
5859 |
0.24 |
chr10_94466409_94466580 | 3.98 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
48363 |
0.13 |
chr3_79537918_79538245 | 3.97 |
Fnip2 |
folliculin interacting protein 2 |
6205 |
0.15 |
chr3_61217316_61217479 | 3.97 |
Gm37719 |
predicted gene, 37719 |
74049 |
0.1 |
chr4_149798966_149799139 | 3.96 |
Gm13065 |
predicted gene 13065 |
5633 |
0.1 |
chr9_50507627_50508109 | 3.96 |
Plet1os |
placenta expressed transcript 1, opposite strand |
45 |
0.96 |
chr1_168598262_168598413 | 3.96 |
1700063I16Rik |
RIKEN cDNA 1700063I16 gene |
77545 |
0.11 |
chr8_109584951_109585129 | 3.90 |
Hp |
haptoglobin |
5868 |
0.14 |
chr8_33842242_33842463 | 3.89 |
Rbpms |
RNA binding protein gene with multiple splicing |
1319 |
0.41 |
chr4_139301929_139302115 | 3.88 |
Pqlc2 |
PQ loop repeat containing 2 |
8615 |
0.1 |
chr1_54850108_54850451 | 3.87 |
Ankrd44 |
ankyrin repeat domain 44 |
34432 |
0.16 |
chr15_99297991_99298171 | 3.87 |
Prpf40b |
pre-mRNA processing factor 40B |
2186 |
0.16 |
chr6_113991518_113991701 | 3.87 |
Gm15083 |
predicted gene 15083 |
13180 |
0.17 |
chr16_21474778_21474944 | 3.87 |
Vps8 |
VPS8 CORVET complex subunit |
4674 |
0.3 |
chr12_102788080_102788385 | 3.86 |
Gm47042 |
predicted gene, 47042 |
23520 |
0.08 |
chr17_47990768_47990919 | 3.86 |
Gm14871 |
predicted gene 14871 |
12729 |
0.14 |
chr2_103870054_103870389 | 3.85 |
Gm13876 |
predicted gene 13876 |
18103 |
0.09 |
chr13_102877226_102877399 | 3.84 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
28474 |
0.23 |
chr8_64716760_64716977 | 3.84 |
Msmo1 |
methylsterol monoxygenase 1 |
5063 |
0.17 |
chr9_95185947_95186148 | 3.83 |
Slc9a9 |
solute carrier family 9 (sodium/hydrogen exchanger), member 9 |
64361 |
0.13 |
chr1_88316276_88316427 | 3.82 |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
2562 |
0.2 |
chr5_146967227_146967378 | 3.81 |
Mtif3 |
mitochondrial translational initiation factor 3 |
3502 |
0.21 |
chr8_94174559_94174710 | 3.80 |
Gm45774 |
predicted gene 45774 |
1222 |
0.26 |
chr8_109993075_109993269 | 3.80 |
Tat |
tyrosine aminotransferase |
2666 |
0.18 |
chr13_111431183_111431339 | 3.79 |
Gpbp1 |
GC-rich promoter binding protein 1 |
22121 |
0.17 |
chrX_129167854_129168016 | 3.79 |
Gm26029 |
predicted gene, 26029 |
11050 |
0.3 |
chr6_115418714_115419284 | 3.78 |
Pparg |
peroxisome proliferator activated receptor gamma |
3067 |
0.27 |
chr7_126494300_126494471 | 3.76 |
Atxn2l |
ataxin 2-like |
1009 |
0.34 |
chr1_88422195_88422354 | 3.76 |
Spp2 |
secreted phosphoprotein 2 |
14868 |
0.15 |
chr14_63306924_63307367 | 3.76 |
Gm49390 |
predicted gene, 49390 |
10600 |
0.16 |
chr8_12842456_12842630 | 3.75 |
Atp11a |
ATPase, class VI, type 11A |
5312 |
0.14 |
chr9_103363870_103364326 | 3.75 |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 |
799 |
0.56 |
chr9_107296057_107296219 | 3.74 |
Cish |
cytokine inducible SH2-containing protein |
112 |
0.9 |
chr9_67604985_67605321 | 3.74 |
Tln2 |
talin 2 |
45450 |
0.15 |
chr11_120628603_120628795 | 3.74 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
1449 |
0.14 |
chr3_101881841_101882004 | 3.73 |
Slc22a15 |
solute carrier family 22 (organic anion/cation transporter), member 15 |
4035 |
0.26 |
chr5_134941937_134942100 | 3.72 |
Mettl27 |
methyltransferase like 27 |
1556 |
0.18 |
chr16_95763340_95763505 | 3.70 |
Gm37259 |
predicted gene, 37259 |
3586 |
0.21 |
chr4_117342819_117343008 | 3.68 |
Rnf220 |
ring finger protein 220 |
32544 |
0.12 |
chr4_150825989_150826153 | 3.67 |
Gm13049 |
predicted gene 13049 |
338 |
0.86 |
chr10_122361947_122362104 | 3.67 |
Gm36041 |
predicted gene, 36041 |
24867 |
0.2 |
chr13_30346992_30347295 | 3.66 |
Agtr1a |
angiotensin II receptor, type 1a |
1602 |
0.41 |
chr4_56927286_56927446 | 3.66 |
Tmem245 |
transmembrane protein 245 |
3908 |
0.17 |
chr3_79252925_79253290 | 3.66 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
33410 |
0.14 |
chr7_19955922_19956099 | 3.66 |
Rpl7a-ps8 |
ribosomal protein L7A, pseudogene 8 |
2227 |
0.14 |
chr4_85773463_85773614 | 3.66 |
Adamtsl1 |
ADAMTS-like 1 |
259211 |
0.02 |
chr9_98422028_98422205 | 3.66 |
Rbp1 |
retinol binding protein 1, cellular |
845 |
0.65 |
chr13_10274143_10274314 | 3.65 |
Gm26861 |
predicted gene, 26861 |
83367 |
0.08 |
chr15_59391938_59392317 | 3.65 |
Nsmce2 |
NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase |
17840 |
0.18 |
chr19_26709232_26709383 | 3.64 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
1241 |
0.55 |
chr8_90391789_90391953 | 3.64 |
Tox3 |
TOX high mobility group box family member 3 |
43528 |
0.2 |
chr12_117857982_117858133 | 3.62 |
Cdca7l |
cell division cycle associated 7 like |
14169 |
0.2 |
chr2_49522677_49522856 | 3.62 |
Epc2 |
enhancer of polycomb homolog 2 |
6109 |
0.29 |
chr1_82974456_82974623 | 3.61 |
Gm47955 |
predicted gene, 47955 |
14253 |
0.08 |
chr6_34901958_34902109 | 3.61 |
Wdr91 |
WD repeat domain 91 |
8530 |
0.13 |
chr11_69110217_69110963 | 3.61 |
Hes7 |
hes family bHLH transcription factor 7 |
9814 |
0.07 |
chr3_18460428_18460786 | 3.59 |
Gm30667 |
predicted gene, 30667 |
647 |
0.74 |
chr6_100415485_100415639 | 3.59 |
Gm23234 |
predicted gene, 23234 |
79252 |
0.08 |
chr4_99028512_99028838 | 3.59 |
Angptl3 |
angiopoietin-like 3 |
2279 |
0.28 |
chr6_87428535_87428790 | 3.58 |
Bmp10 |
bone morphogenetic protein 10 |
332 |
0.85 |
chr14_78937878_78938029 | 3.58 |
Gm49016 |
predicted gene, 49016 |
9274 |
0.2 |
chr1_9906956_9907361 | 3.56 |
Mcmdc2 |
minichromosome maintenance domain containing 2 |
1480 |
0.29 |
chr5_35856357_35856514 | 3.54 |
Ablim2 |
actin-binding LIM protein 2 |
631 |
0.75 |
chr13_100532997_100533171 | 3.53 |
Ocln |
occludin |
19376 |
0.11 |
chr14_26432359_26432703 | 3.52 |
Slmap |
sarcolemma associated protein |
2430 |
0.24 |
chrX_60347501_60348092 | 3.52 |
Mir505 |
microRNA 505 |
46696 |
0.14 |
chr1_164215221_164215636 | 3.51 |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
33618 |
0.11 |
chr10_119497804_119497974 | 3.51 |
Gm47342 |
predicted gene, 47342 |
25949 |
0.11 |
chr14_63479379_63479556 | 3.49 |
Gm47074 |
predicted gene, 47074 |
4091 |
0.16 |
chr18_23496939_23497187 | 3.46 |
Dtna |
dystrobrevin alpha |
228 |
0.96 |
chr13_81316192_81316649 | 3.46 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
26416 |
0.22 |
chr10_95426399_95426797 | 3.44 |
5730420D15Rik |
RIKEN cDNA 5730420D15 gene |
9223 |
0.12 |
chr17_86593218_86593401 | 3.44 |
Gm10309 |
predicted gene 10309 |
88077 |
0.07 |
chr5_107046594_107046884 | 3.44 |
Gm33474 |
predicted gene, 33474 |
2097 |
0.34 |
chr18_65099329_65099521 | 3.44 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
16371 |
0.23 |
chr5_138760297_138760459 | 3.43 |
Fam20c |
family with sequence similarity 20, member C |
5291 |
0.21 |
chr4_126017743_126017905 | 3.41 |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
6726 |
0.16 |
chrX_101676822_101676979 | 3.39 |
Gm14845 |
predicted gene 14845 |
14950 |
0.12 |
chr3_29243592_29243779 | 3.39 |
Gm37965 |
predicted gene, 37965 |
23798 |
0.23 |
chr10_72778559_72778735 | 3.38 |
Gm47094 |
predicted gene, 47094 |
60716 |
0.14 |
chr14_63822463_63822616 | 3.38 |
Xkr6 |
X-linked Kx blood group related 6 |
27520 |
0.17 |
chr2_51512722_51513109 | 3.36 |
Gm23505 |
predicted gene, 23505 |
19133 |
0.19 |
chr1_165609107_165609258 | 3.35 |
Mpzl1 |
myelin protein zero-like 1 |
364 |
0.78 |
chr2_152817536_152817750 | 3.35 |
Bcl2l1 |
BCL2-like 1 |
10892 |
0.12 |
chr14_60702846_60703006 | 3.33 |
Spata13 |
spermatogenesis associated 13 |
27 |
0.98 |
chr11_31220965_31221131 | 3.33 |
Gm12106 |
predicted gene 12106 |
36674 |
0.16 |
chr6_125575019_125575372 | 3.32 |
Vwf |
Von Willebrand factor |
8944 |
0.21 |
chr12_71719042_71719430 | 3.32 |
Gm47555 |
predicted gene, 47555 |
35149 |
0.17 |
chr4_41630291_41630458 | 3.32 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
1270 |
0.29 |
chr13_29360810_29360976 | 3.32 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
113714 |
0.07 |
chr8_126838292_126838477 | 3.31 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
849 |
0.65 |
chr2_4900502_4900665 | 3.31 |
Sephs1 |
selenophosphate synthetase 1 |
16199 |
0.13 |
chr15_26779223_26779382 | 3.31 |
Gm49266 |
predicted gene, 49266 |
33165 |
0.17 |
chr3_94649301_94649483 | 3.30 |
Gm10972 |
predicted gene 10972 |
6294 |
0.1 |
chr8_18770899_18771050 | 3.30 |
Angpt2 |
angiopoietin 2 |
29412 |
0.16 |
chr1_190169932_190170307 | 3.30 |
Prox1os |
prospero homeobox 1, opposite strand |
177 |
0.81 |
chr17_72904064_72904328 | 3.29 |
Lbh |
limb-bud and heart |
14109 |
0.23 |
chr2_14250237_14250428 | 3.29 |
Mir511 |
microRNA 511 |
10671 |
0.17 |
chr3_121346684_121346853 | 3.29 |
Gm5711 |
predicted gene 5711 |
33911 |
0.12 |
chr16_22439730_22439912 | 3.29 |
Etv5 |
ets variant 5 |
102 |
0.97 |
chr11_16704048_16704199 | 3.28 |
Gm25698 |
predicted gene, 25698 |
28588 |
0.15 |
chr2_115093304_115093458 | 3.27 |
Gm28493 |
predicted gene 28493 |
42169 |
0.17 |
chr14_25528965_25529155 | 3.26 |
Mir3075 |
microRNA 3075 |
5379 |
0.18 |
chr7_81872575_81872742 | 3.26 |
Tm6sf1 |
transmembrane 6 superfamily member 1 |
835 |
0.4 |
chr8_36692402_36692571 | 3.25 |
Dlc1 |
deleted in liver cancer 1 |
40568 |
0.2 |
chr17_70797462_70797613 | 3.25 |
Gm41609 |
predicted gene, 41609 |
8460 |
0.13 |
chr19_55276833_55277005 | 3.23 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
4049 |
0.21 |
chr6_115615858_115616133 | 3.23 |
Raf1 |
v-raf-leukemia viral oncogene 1 |
4323 |
0.13 |
chr12_76009151_76009311 | 3.22 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
13069 |
0.25 |
chr14_47883630_47883799 | 3.22 |
4930447J18Rik |
RIKEN cDNA 4930447J18 gene |
15137 |
0.17 |
chr19_10901185_10901365 | 3.21 |
Prpf19 |
pre-mRNA processing factor 19 |
993 |
0.37 |
chr2_71032072_71032241 | 3.21 |
Mettl8 |
methyltransferase like 8 |
13778 |
0.2 |
chr2_174660432_174660583 | 3.20 |
Zfp831 |
zinc finger protein 831 |
16973 |
0.21 |
chr12_91768973_91769144 | 3.20 |
Ston2 |
stonin 2 |
2112 |
0.29 |
chr2_152361963_152362124 | 3.20 |
Gm14165 |
predicted gene 14165 |
8428 |
0.09 |
chr6_125333213_125333391 | 3.20 |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
11781 |
0.1 |
chr6_28779093_28779393 | 3.19 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
2695 |
0.29 |
chr10_75049052_75049276 | 3.19 |
Rab36 |
RAB36, member RAS oncogene family |
10941 |
0.15 |
chr2_102133077_102133241 | 3.19 |
Ldlrad3 |
low density lipoprotein receptor class A domain containing 3 |
4960 |
0.24 |
chr10_44084446_44084597 | 3.19 |
Crybg1 |
crystallin beta-gamma domain containing 1 |
25743 |
0.17 |
chr14_10441490_10441641 | 3.19 |
Fhit |
fragile histidine triad gene |
11893 |
0.23 |
chr14_28652150_28652318 | 3.19 |
Gm35164 |
predicted gene, 35164 |
2475 |
0.38 |
chr5_113204337_113204488 | 3.18 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
16824 |
0.12 |
chr6_99991198_99991358 | 3.18 |
Gm33201 |
predicted gene, 33201 |
63 |
0.98 |
chr15_66183079_66183248 | 3.18 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
79909 |
0.09 |
chr14_117130450_117130601 | 3.17 |
Gpc6 |
glypican 6 |
204589 |
0.03 |
chr17_86165279_86165510 | 3.16 |
Prkce |
protein kinase C, epsilon |
2391 |
0.3 |
chr9_31290585_31290752 | 3.16 |
4930517E14Rik |
Riken cDNA 4930517E14 gene |
9676 |
0.16 |
chr2_121138091_121138271 | 3.15 |
Lcmt2 |
leucine carboxyl methyltransferase 2 |
2197 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.0 | 10.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 5.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.6 | 7.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.5 | 4.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.4 | 4.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.4 | 4.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.3 | 4.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.2 | 5.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.2 | 2.4 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.2 | 2.4 | GO:0021564 | vagus nerve development(GO:0021564) |
1.2 | 3.5 | GO:0015817 | histidine transport(GO:0015817) |
1.1 | 3.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.1 | 5.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.0 | 4.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.0 | 1.0 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.0 | 2.9 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.0 | 4.9 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.0 | 2.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.0 | 2.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.0 | 3.8 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.9 | 8.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.9 | 2.8 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.9 | 3.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.9 | 4.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.9 | 2.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.9 | 2.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.9 | 3.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.9 | 1.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.9 | 1.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.9 | 1.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.8 | 0.8 | GO:0003164 | His-Purkinje system development(GO:0003164) bundle of His development(GO:0003166) |
0.8 | 2.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.8 | 2.5 | GO:0070384 | Harderian gland development(GO:0070384) |
0.8 | 2.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.8 | 0.8 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.8 | 2.4 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.8 | 0.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.8 | 1.6 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.8 | 0.8 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.8 | 3.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.8 | 6.9 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.8 | 3.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 4.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.7 | 4.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 2.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.7 | 1.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.7 | 2.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.7 | 4.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.7 | 1.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.7 | 1.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.7 | 2.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.7 | 1.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 3.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.7 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.7 | 3.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 2.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.7 | 1.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.7 | 2.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 1.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 1.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.6 | 3.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 3.1 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.6 | 3.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.6 | 1.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.6 | 1.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.6 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.6 | 1.8 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 2.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.6 | 1.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 1.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 2.3 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.6 | 4.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.6 | 1.7 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.6 | 1.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 5.7 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.6 | 3.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 2.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.6 | 1.7 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.6 | 1.1 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.6 | 1.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 1.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 3.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 1.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 2.1 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.5 | 0.5 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.5 | 0.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 0.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 2.6 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 1.5 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 1.0 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.5 | 2.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 4.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 1.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 1.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.5 | 1.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 3.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 0.5 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.5 | 1.4 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 0.5 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.5 | 0.9 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.5 | 1.8 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 1.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 1.4 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.5 | 1.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.5 | 2.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 2.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.5 | 1.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.4 | 1.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 0.4 | GO:2000591 | cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 1.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 4.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 1.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 1.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 1.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 1.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 1.3 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 3.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 2.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 5.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 1.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 1.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 1.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.4 | 1.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.4 | 0.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 1.7 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 2.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.4 | 1.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 0.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 0.8 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.4 | 1.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 1.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.4 | 3.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.4 | 2.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 1.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.4 | 0.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 0.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 2.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 1.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 0.4 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.4 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 0.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.4 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 3.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.4 | 1.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 2.2 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 1.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.4 | 1.8 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.4 | 1.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 1.4 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.4 | 7.6 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 1.8 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.4 | 1.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 1.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.4 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 0.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 1.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 1.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 1.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 2.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.7 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 2.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 1.0 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 1.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 1.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.3 | 0.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.3 | 1.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 1.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.3 | 0.7 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.3 | 1.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 2.7 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 2.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 0.3 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 1.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 1.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 1.0 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 2.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 7.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 0.3 | GO:0043307 | eosinophil activation(GO:0043307) |
0.3 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 1.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 1.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 1.6 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.6 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 1.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 0.3 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.3 | 0.9 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.3 | 1.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 0.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 1.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 0.6 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.3 | 0.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.3 | 2.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 0.6 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 1.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 2.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 0.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 2.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 0.3 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.3 | 1.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 0.9 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 0.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 2.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 2.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.3 | 1.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 0.9 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 0.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 1.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 0.3 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.3 | 0.3 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 2.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.3 | 0.3 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 1.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 0.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 1.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 2.9 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 2.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.6 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 0.9 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 0.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 1.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 2.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 0.8 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) negative regulation of vascular smooth muscle cell proliferation(GO:1904706) vascular smooth muscle cell proliferation(GO:1990874) |
0.3 | 1.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 1.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 1.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 0.8 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 0.8 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.3 | 1.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 0.3 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.3 | 0.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 1.1 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 3.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.3 | 0.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.3 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.3 | 1.6 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 1.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.8 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 0.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 1.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 1.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.3 | 0.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.3 | 0.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 1.9 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 0.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 0.5 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 2.9 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 0.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 1.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 1.0 | GO:0006848 | pyruvate transport(GO:0006848) |
0.3 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 0.3 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.3 | 2.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 0.5 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.3 | 0.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 1.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 1.0 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 0.5 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 2.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 0.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.3 | 0.5 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.8 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.3 | 0.3 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.3 | 0.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.3 | 2.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 2.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 1.3 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 0.5 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.2 | 0.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 3.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 1.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 0.5 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.2 | 0.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 1.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.5 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.2 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.2 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 2.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.7 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 1.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 5.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.7 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 1.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 1.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 1.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.5 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 1.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.5 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 2.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 1.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.2 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.2 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.2 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 3.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 2.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.4 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 1.3 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 2.7 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 1.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.7 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 1.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.7 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.2 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 1.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 1.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.2 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 2.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.4 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 0.8 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 1.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 1.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 1.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 4.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 2.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 4.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 0.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 1.6 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.2 | 0.4 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 0.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.4 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 1.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.6 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 2.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 1.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 1.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 1.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 0.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 1.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 1.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.6 | GO:0001781 | neutrophil apoptotic process(GO:0001781) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.4 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 0.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 1.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 1.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 1.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 2.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 1.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.4 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.2 | 1.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 1.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 3.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.6 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.2 | 0.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 0.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.6 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 1.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 0.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.4 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.5 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 1.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.2 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.2 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 5.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.8 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 0.9 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 6.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 1.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.5 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 1.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 0.9 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.5 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 1.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 1.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 1.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.2 | 0.2 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 1.0 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.5 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.8 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 3.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.2 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.3 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 1.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 1.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.7 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.2 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 1.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.2 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.2 | 0.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 1.0 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.2 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 1.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 1.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 0.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.2 | 0.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.2 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.6 | GO:0009838 | abscission(GO:0009838) |
0.2 | 1.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.3 | GO:0070293 | renal absorption(GO:0070293) |
0.2 | 0.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 1.1 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.2 | 2.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.6 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.8 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.3 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 0.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.5 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 2.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.5 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 1.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.6 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.5 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.2 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 1.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 0.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 0.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.2 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 2.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.1 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.4 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.1 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.1 | 0.3 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 1.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.1 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.1 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.1 | 2.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 2.7 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.3 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.4 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.3 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.3 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.3 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.1 | GO:0051610 | serotonin uptake(GO:0051610) |
0.1 | 1.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 1.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 1.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.1 | GO:0003181 | atrioventricular valve morphogenesis(GO:0003181) |
0.1 | 0.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 1.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.5 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 2.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.1 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 1.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 1.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 1.1 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 2.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 1.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.5 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 1.2 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.1 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 1.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.6 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.9 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 1.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.2 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.2 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.5 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.1 | 0.7 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.6 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.1 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 1.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 0.4 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.6 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 2.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.7 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 1.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.1 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.1 | 0.2 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.1 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 1.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 1.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.1 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.1 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.2 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 1.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.3 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.6 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.9 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 2.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.3 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 1.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.4 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.4 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 3.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.2 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 2.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.3 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.2 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.6 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.1 | GO:0006189 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 1.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.5 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.1 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.4 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 1.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.8 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.4 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.6 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.8 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 4.0 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.4 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.1 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.1 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.8 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 3.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.4 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.6 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.3 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.1 | 3.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.3 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.3 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 1.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.6 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 7.0 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.2 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.1 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.4 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.1 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.1 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 1.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.6 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 1.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.9 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.1 | 1.1 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.7 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.8 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.4 | GO:0030810 | positive regulation of nucleotide biosynthetic process(GO:0030810) positive regulation of purine nucleotide biosynthetic process(GO:1900373) |
0.1 | 0.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 1.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 1.9 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.1 | 0.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.5 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 1.0 | GO:1902667 | regulation of axon extension involved in axon guidance(GO:0048841) negative regulation of axon extension involved in axon guidance(GO:0048843) regulation of axon guidance(GO:1902667) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.8 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 6.0 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 0.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.3 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 1.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.8 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 1.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 2.1 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.2 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
0.1 | 0.4 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.6 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 2.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.3 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.1 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.1 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.9 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.1 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 1.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 1.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.3 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 1.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 1.6 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 2.5 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.0 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.4 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 1.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.1 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.0 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.4 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.0 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.0 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.5 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.0 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.5 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.3 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.3 | GO:0036230 | granulocyte activation(GO:0036230) |
0.0 | 0.0 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.0 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 4.0 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.3 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.0 | 0.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.0 | 0.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 1.4 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.0 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.0 | 0.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.0 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.2 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.1 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.0 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.5 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.1 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0034436 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) glycoprotein transport(GO:0034436) |
0.0 | 0.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.1 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.1 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.0 | GO:0031652 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.0 | 0.5 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.0 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.0 | 0.0 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.0 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.0 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 1.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.0 | GO:0021626 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.0 | 0.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.0 | 0.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0034776 | response to histamine(GO:0034776) |
0.0 | 0.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.3 | 9.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.2 | 7.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.1 | 3.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.9 | 3.6 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.9 | 4.4 | GO:0005767 | secondary lysosome(GO:0005767) |
0.8 | 2.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 2.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.7 | 9.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.7 | 3.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 1.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.7 | 2.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 2.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 1.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.6 | 4.0 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.5 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 3.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 1.5 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.5 | 2.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 1.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 5.1 | GO:0042627 | chylomicron(GO:0042627) |
0.5 | 2.3 | GO:0097433 | dense body(GO:0097433) |
0.4 | 2.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.4 | 1.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 2.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 0.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 0.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 2.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 1.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 0.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 1.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 1.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 1.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.4 | 1.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 1.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 1.8 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 1.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 3.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 1.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 2.4 | GO:0000801 | central element(GO:0000801) |
0.3 | 5.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 2.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 1.0 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 3.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 2.3 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 1.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 2.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 0.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 0.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 2.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 3.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 2.3 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 0.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 2.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 4.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 2.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 3.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 5.5 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 3.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 1.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 1.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.7 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.0 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 1.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 3.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 1.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 2.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.9 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.6 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 1.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 3.3 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 1.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 5.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.7 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 8.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 0.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.7 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 2.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 1.3 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.5 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 4.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 2.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 2.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 2.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 1.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 5.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 1.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 2.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 5.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 2.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 2.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 5.2 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.1 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.5 | GO:0005818 | aster(GO:0005818) |
0.1 | 1.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 3.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 2.3 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 8.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 2.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 1.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 1.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.7 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 1.3 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 4.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 4.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 4.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 3.4 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 6.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 3.2 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 1.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 4.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 2.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 1.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 4.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.9 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 11.8 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.8 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 11.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 1.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 1.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.9 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 1.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 25.0 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 2.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 49.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 2.6 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 1.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 1.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.0 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 1.5 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 3.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 7.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 34.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 10.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 5.3 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 1.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.8 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 3.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 1.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 1.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.0 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 1.2 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.0 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 37.3 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.4 | 4.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 3.8 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.1 | 3.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.0 | 4.2 | GO:0031433 | telethonin binding(GO:0031433) |
1.0 | 2.0 | GO:0043398 | HLH domain binding(GO:0043398) |
1.0 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.0 | 2.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 3.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.9 | 4.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 2.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 6.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.8 | 3.9 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.8 | 3.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 2.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.8 | 2.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.8 | 2.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.7 | 4.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 4.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 2.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.7 | 2.9 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.7 | 2.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.6 | 3.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 4.5 | GO:0018656 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 1.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 3.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.6 | 2.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 10.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 1.8 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.6 | 0.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.6 | 1.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 2.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 1.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 0.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.5 | 1.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 1.6 | GO:2001069 | glycogen binding(GO:2001069) |
0.5 | 2.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.5 | 1.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 3.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.5 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 2.6 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.5 | 6.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 6.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 3.9 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 1.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 3.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 1.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 1.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 6.3 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 1.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 4.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 1.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.4 | 0.9 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 2.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 3.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 1.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 2.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 2.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 2.0 | GO:0070061 | fructose binding(GO:0070061) |
0.4 | 1.6 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.4 | 2.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 2.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 2.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 4.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 1.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 1.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 1.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.1 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 13.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 3.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.4 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 1.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 2.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 2.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 1.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 2.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.4 | 1.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 2.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 2.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 2.1 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.3 | 1.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 2.7 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 1.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 3.3 | GO:0048038 | quinone binding(GO:0048038) |
0.3 | 1.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 2.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 3.8 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 0.9 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 4.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 1.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 0.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 2.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.8 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 3.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 0.6 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 1.4 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.3 | 1.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 1.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 8.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 4.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.3 | 0.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 4.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.3 | 1.9 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 1.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.3 | 4.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 1.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 0.8 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 0.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.3 | 1.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 2.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.5 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 2.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 1.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.9 | GO:0015265 | urea channel activity(GO:0015265) |
0.2 | 1.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.7 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 1.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 7.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 4.4 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 1.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 3.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.6 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 1.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.1 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.2 | 1.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 5.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 1.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 9.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.2 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 1.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 2.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 4.9 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 2.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 1.9 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.2 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 0.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 1.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 2.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.4 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 4.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.9 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 9.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.7 | GO:0102344 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 2.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 1.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 7.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 1.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 2.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.8 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 1.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.3 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.2 | 0.8 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 5.3 | GO:0019111 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.2 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 4.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.2 | 1.8 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 4.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 1.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.5 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.5 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 1.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 1.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 2.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.9 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 1.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 1.6 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 2.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 25.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 4.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 2.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 1.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 3.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 3.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.6 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 2.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 1.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:0019114 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 6.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.1 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.4 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 2.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.0 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.8 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 2.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 1.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 3.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 11.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 1.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 2.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 1.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 2.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.0 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 2.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 1.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 2.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 2.9 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.9 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 4.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 1.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 3.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 2.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 1.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 3.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 3.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.5 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.3 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 1.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.7 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 1.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 2.4 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 4.8 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 1.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 2.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 4.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 5.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.0 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 1.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 1.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 2.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 1.3 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 2.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 1.5 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 2.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.5 | GO:0015081 | sodium ion transmembrane transporter activity(GO:0015081) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 4.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 2.8 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 2.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 0.2 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 1.2 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 1.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 6.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 1.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 2.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.7 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 0.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 4.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 22.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.5 | 8.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 10.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 8.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 12.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 1.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 5.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 12.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 2.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 3.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 16.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 4.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 3.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 1.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 14.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 9.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 2.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 6.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 3.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 2.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 3.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 3.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 1.4 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 6.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 2.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 3.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 3.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 4.2 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 3.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.8 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 6.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 5.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 5.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 3.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 4.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 20.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 3.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 4.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 7.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 4.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.8 | 7.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.8 | 10.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 2.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 8.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.6 | 1.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 6.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 3.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 1.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 4.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 1.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 5.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 3.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 2.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 5.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 3.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 2.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 3.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 2.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 3.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 8.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 6.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 0.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 3.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 3.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 2.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 0.5 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.3 | 7.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 2.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 2.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 1.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 6.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 8.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 2.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 4.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 9.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 2.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 1.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 1.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 0.4 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.2 | 5.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 2.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 5.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 4.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 1.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 4.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 0.5 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 8.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 1.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 2.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 4.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 0.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 4.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 1.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 6.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.3 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 4.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 1.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 9.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 3.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 9.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 2.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 4.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.9 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 1.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 10.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 3.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.8 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 2.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 2.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 4.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 3.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 2.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.6 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 1.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 4.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 2.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 2.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.8 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 1.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.0 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.0 | 0.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.0 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.0 | 0.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.0 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |